Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACE: Selexipag in PAH
NCT03078907Phase 4Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Nov 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of selexipag in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Nov 2017; status: completed.
02
Drugs
selexipag
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03078907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078907.